Vanguard Group Inc Biomerica Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Biomerica Inc stock. As of the latest transaction made, Vanguard Group Inc holds 169,010 shares of BMRA stock, worth $141,968. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,010
Previous 169,010
-0.0%
Holding current value
$141,968
Previous $55,000
5.45%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMRA
# of Institutions
26Shares Held
1.59MCall Options Held
23.3KPut Options Held
0-
Granahan Investment Management, LLC Waltham, MA659KShares$553,3640.01% of portfolio
-
Potomac Capital Management, Inc.168KShares$140,8680.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$125,2280.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$99,5420.0% of portfolio
-
Two Sigma Securities, LLC New York, NY55.2KShares$46,3630.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $11.3M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...